Abstract
Radical nephrectomy is well established as the standard treatment for localized renal cell carcinoma. Nephrectomy is the only known curative therapy for this tumor. The role of radical nephrectomy in the management of metastatic renal cell carcinoma is controversial and has come under increased scrutiny in the past several years with the development of immunotherapy, which has the potential to cure systemic renal cell carcinoma. Thus, immunotherapy combined with radical nephrectomy has the potential to cure patients with metastatic disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Johnson DE, Kaesler KE, Samuels ML (1975) Is nephrectomy justified in patients with metastatic renal cell carcinoma. J Urol 114: 27
Klugo RC, Detmers M, Stiles RE et al. (1977) Aggressive versus conservative management of stage IV renal cell carcinoma. J Urol 118: 244
Montie JE, Stewart BH, Straffon RA et al. (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 117: 272
Patel NP, Lavengood RW (1978) Renal cell carcinoma: natural history and results of treatment. J Urol 119: 722
Frank J (1992) Nephrectomy in metastatic renal cell carcinoma. J Urol 147: 421A
Tolia BM, Whitmore WF (1975) Solitary metastases from renal cell carcinoma. J Urol 114: 836
Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97: 973
deKernion JB, Ramming KD, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148
O’Dea MJ, Zincke H, Utz DC et al. (1978) The treatment of renal cell carcinoma with solitary metastases. J Urol 120: 540
Bukowski R, Murthy S, Klein EA et al. Tumor infiltrating lymphocytes in metastatic renal cell carcinoma: the Cleveland clinic experience. In: Klein EA, Bukowski R, Finke J (eds) The immunobiology of renal cell carcinoma, (in press)
Belldegrun A, Webb DE, Austin HA et al. (1989) Renal toxicity of interleukin-II administration in patients with metastatic renal cell cancer: effect of pretherapy nephrectomy. J Urol 141: 499
Robertson CN, Linehan WM, Pass HI et al. (1990) Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma, treated with adoptive immunotherapy with interleukin-II or interleukin-II plus lymphokine-activated killer cells. J Urol 144: 614
Fleischmann J, Kim B (1991) Interleukin-2 immunotherapy followed by resection of residual renal cell carcinoma. J Urol 145: 938
Spencer WF, Linehan WM, Walther MM et al. (1992) Immunotherapy with IL-2 and alpha interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study. J Urol 147: 24
Fowler JE (1987) Urol Clin North Am 14: 745–756
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Klein, E.A. (1994). The Role of Nephrectomy in Metastatic Renal Cell Carcinoma. In: Staehler, G., Pomer, S. (eds) Contemporary Research on Renal Cell Carcinoma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78609-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-78609-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78611-2
Online ISBN: 978-3-642-78609-9
eBook Packages: Springer Book Archive